This reduction aligns with previous reports of decreased LC3B levels in α-Syn-overexpressing mid-brain neurons and PD patients’ cerebrospinal fluid, suggesting that α-Syn can reduce LC3B levels by reducing its synthesis rather than increasing its degradation by lysosomes [57, 58]. Here, MAP1LC3B is linked to Parkinson disease.